Neumora Therapeutics, Inc. Common Stock

NMRA

$ -

Review earnings summary, surprise history, and upcoming forecasts.

account_balance_walletEarnings Summary

Updated: 05/07/2026FY2026 Q1

Revenue (TTM)

0M USD

YoY -

Net Income (TTM)

-53M USD

YoY Reduced Deficit

Equity Ratio

45.9%

YoY -43.0pt

BPS

0.39$

YoY -72.2%

Revenue

FY2024 Q2$0

FY2024 Q3$0

FY2024 Q4$0

FY2025 Q1$0

FY2025 Q2$0

FY2025 Q3$0

FY2025 Q4$0

FY2026 Q1$0

Actual

YoY$0 (-)

Net Income

$-53.5M

FY2024 Q2$-112.4M

$-112.4M

FY2024 Q3$-185M

$-185M

Surprise History

Actual RevenueAnalyst Estimate

FY2021

Actual:$0

FY2021

FY2022